Change in oxcarbazepine (Trileptal) formulation is associated with more side effects and higher blood concentrations.
Edelbroek
P M
PM
Augustijn
P B
PB
de Haan
G J
GJ
Rademaker
M V
MV
Geesink
H H
HH
D000927:Anticonvulsants / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D000078330:Oxcarbazepine
D000927:Anticonvulsants; D002220:Carbamazepine; D000078330:Oxcarbazepine